Active-ingredient Dossier
Metoclopramide Hydrochloride
Active-ingredient Dossier for Metoclopramide Hydrochloride (antiemetic and prokinetic agent). Australian brands, products, PBS listings, PBAC outcomes —…
- Brand: Metoclopramide
- Brand: ANAGRAINE
- Brand: CLOVOMET
- Brand: EMEXLON
- Brand: MAXOLON
- Brand: METOCLOPRAMIDE
- Therapeutic area: Gastroenterology
- Therapeutic area: Pain Management
- Therapeutic area: Infectious Disease
What is
Metoclopramide Hydrochloride Metoclopramide Hydrochloride is an antiemetic and prokinetic agent.
Australian brands containing
Metoclopramide Hydrochloride — Metoclopramide — ANAGRAINE — CLOVOMET — EMEXLON — METOCLOPRAMIDE-BAXTER — METOCLOPRAMIDE-WGR
Therapeutic areas
Metoclopramide Hydrochloride is registered across multiple therapeutic areas: Infectious Disease (6 brands), Pain Management (1 brand), Complementary Medicine (1 brand), and Oncology (1 brand).
Sponsor landscape
The ingredient is marketed by six sponsors: Ipca Pharma, Aspen Pharmacare, Arrotex Pharmaceuticals, Pfizer (Perth), Baxter Healthcare, and GM Pharma.
PBS and regulatory activity
One brand containing Metoclopramide Hydrochloride has PBS-listed items, with the latest PBS schedule date of 2026-05-01.